Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma

NCT01334515 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Neuroblastoma

Interventions

BIOLOGICAL: hu14.18-IL2 fusion protein
DRUG: isotretinoin
BIOLOGICAL: sargramostim
OTHER: laboratory biomarker analysis

Sponsor

Children's Oncology Group

Collaborators

[object Object]